These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38328231)
41. Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors. Janeczko M; Masłyk M; Szyszka R; Baier A Mol Cell Biochem; 2011 Oct; 356(1-2):121-6. PubMed ID: 21755460 [TBL] [Abstract][Full Text] [Related]
42. Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2α' levels. Olsen BB; Fischer U; Rasmussen TL; Montenarh M; Meese E; Fritz G; Issinger OG Mol Cell Biochem; 2011 Oct; 356(1-2):139-47. PubMed ID: 21750982 [TBL] [Abstract][Full Text] [Related]
43. Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening. Nienberg C; Garmann C; Gratz A; Bollacke A; Götz C; Jose J Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28067769 [TBL] [Abstract][Full Text] [Related]
44. Protein kinase casein kinase 2 holoenzyme produced ectopically in human cells can be exported to the external side of the cellular membrane. Rodríguez F; Allende CC; Allende JE Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4718-23. PubMed ID: 15774585 [TBL] [Abstract][Full Text] [Related]
45. Assembly of protein kinase CK2: investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta. Canton DA; Zhang C; Litchfield DW Biochem J; 2001 Aug; 358(Pt 1):87-94. PubMed ID: 11485555 [TBL] [Abstract][Full Text] [Related]
46. Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor. Niefind K; Bischoff N; Golub AG; Bdzhola VG; Balanda AO; Prykhod'ko AO; Yarmoluk SM Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28085026 [TBL] [Abstract][Full Text] [Related]
47. Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process. Dörr J; Kartarius S; Götz C; Montenarh M Mol Cell Biochem; 2008 Sep; 316(1-2):187-93. PubMed ID: 18553058 [TBL] [Abstract][Full Text] [Related]
48. The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven. Raaf J; Brunstein E; Issinger OG; Niefind K Protein Sci; 2008 Dec; 17(12):2180-6. PubMed ID: 18824508 [TBL] [Abstract][Full Text] [Related]
49. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit. Baier A; Nazaruk J; Galicka A; Szyszka R Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536 [TBL] [Abstract][Full Text] [Related]
50. Ecto-protein kinase CK2, the neglected form of CK2. Montenarh M; Götz C Biomed Rep; 2018 Apr; 8(4):307-313. PubMed ID: 29556379 [TBL] [Abstract][Full Text] [Related]
51. [Screening ubiquitin/ribosomal protein S27a by yeast two-hybridization system]. Huang GH; Liang JY; Chen B; Liu XG; Liang NC Ai Zheng; 2005 Jan; 24(1):40-6. PubMed ID: 15642198 [TBL] [Abstract][Full Text] [Related]
52. Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies. Chen JM; Gao C; Shi Q; Shan B; Lei YJ; Dong CF; An R; Wang GR; Zhang BY; Han J; Dong XP Arch Virol; 2008; 153(6):1013-20. PubMed ID: 18404245 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats. Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012 [TBL] [Abstract][Full Text] [Related]
55. Yeast surviving factor Svf1 as a new interacting partner, regulator and in vitro substrate of protein kinase CK2. Masłyk M; Kochanowicz E; Zieliński R; Kubiński K; Hellman U; Szyszka R Mol Cell Biochem; 2008 May; 312(1-2):61-9. PubMed ID: 18265947 [TBL] [Abstract][Full Text] [Related]
56. Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme. Niefind K; Issinger OG Mol Cell Biochem; 2005 Jun; 274(1-2):3-14. PubMed ID: 16335523 [TBL] [Abstract][Full Text] [Related]
57. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2. Raaf J; Issinger OG; Niefind K J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447 [TBL] [Abstract][Full Text] [Related]
58. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2. Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103 [TBL] [Abstract][Full Text] [Related]
59. Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons. Lettieri A; Borgo C; Zanieri L; D'Amore C; Oleari R; Paganoni A; Pinna LA; Cariboni A; Salvi M Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779225 [TBL] [Abstract][Full Text] [Related]
60. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction. Hochscherf J; Lindenblatt D; Steinkrüger M; Yoo E; Ulucan Ö; Herzig S; Issinger OG; Helms V; Götz C; Neundorf I; Niefind K; Pietsch M Anal Biochem; 2015 Jan; 468():4-14. PubMed ID: 25233003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]